AGREEMENT

EXHIBIT 1

AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.01 par value, of Biocryst Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.

June 1, 2009

	By:	/s/ Xxxxxx X. Xxxxx
		Xxxxxx X. Xxxxx
	By:	/s/ Xxxxx X. Xxxxx
		Xxxxx X. Xxxxx